Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form
Cardiovascular diseases such as hypertension and cardiac failure in South African children and adolescents are effectively managed long term, using a combination treatment of captopril and hydrochlorothiazide. The majority of commercially available pharmaceutical products are designed for adult pati...
Saved in:
Main Authors: | Mellisa T. R. Chikukwa (Author), Roderick B. Walker (Author), Sandile M. M. Khamanga (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation
by: Pedzisai A. Makoni, et al.
Published: (2019) -
Microparticulated Mefenamic Acid with High Dispersion Stability for Pediatric Dosage Form
by: Moe Yamazaki, et al.
Published: (2022) -
An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System
by: Arthur Manda, et al.
Published: (2019) -
Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms
by: Constain H. Salamanca, et al.
Published: (2018) -
Design, Optimization, Manufacture and Characterization of Efavirenz-Loaded Flaxseed Oil Nanoemulsions
by: Priveledge Mazonde, et al.
Published: (2020)